Eliglustat (Cerdelga) Approved in Europe for Gaucher DiseaseEliglustat (Cerdelga) Approved in Europe for Gaucher Disease

The oral glucosylceramide analog is indicated for long-term treatment of adults with type 1 Gaucher disease. International Approvals

Source: Medscape Medical News Headlines - January 23, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news